AstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges
Second-quarter sales of AstraZeneca's (AZN.L) COVID-19 vaccine more than tripled to $894 million from
Please be informed that a specific anonymous source is attempting a cyber-attack to damage the reputation of World Economic Magazine. They might attempt to access your personal or professional email under the guise of making untrue accusations against our company via email, the internet, etc. You are urged to use extreme caution when receiving such emails because these statements are false and fraudulent.
Please note that we never owed any monetary dues to any party whatsoever. Any agency or source claiming otherwise, is doing so solely with a deceitful intention and is a part of fraudulent activities
Second-quarter sales of AstraZeneca's (AZN.L) COVID-19 vaccine more than tripled to $894 million from
Asian shares managed a semblance of calm on Thursday as the U.S. Federal Reserve
Facebook Inc (FB.O) said on Wednesday it expects revenue growth to "decelerate significantly," sending
Europe's Airbus (AIR.PA) took aim at one of Boeing's (BA.N) most profitable strongholds on
Samsung Electronics Co Ltd (005930.KS) on Thursday forecast strong demand for memory chips in
Shares of PayPal Holdings Inc(PYPL.O) fell 8% on the payment company's downbeat current-quarter profit
Language learning app Duolingo Inc (DUOL.O) notched a valuation of $6.5 billion after its
U.S. stocks and the dollar slipped on Wednesday in listless trade after the Federal
Google parent Alphabet Inc's (GOOGL.O) quarterly revenue and profit surged to record highs, the
Spain's Santander (SAN.MC) beat forecasts with a 35% jump in second-quarter underlying profit on